1

How eCTD v4.0 Is Reshaping Regulatory Submissions: What Pharma Needs to Know in 2025

News Discuss 
ECTD v4.0 introduces a transformative approach to regulatory submissions, emphasizing metadata-driven structures, enhanced document reuse, and improved interoperability across global agencies. This evolution aims to streamline the submission process, reduce redundancies, and facilitate smoother regulatory reviews. With major agencies like the FDA and PMDA adopting eCTD v4.0, pharmaceu... https://japan.freyrsolutions.com/blogs/how-ectd-v4-0-is-reshaping-regulatory-submissions-what-pharma-needs-to-know-in-2025

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story